Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NQ: SNY )

49.69 +0.05 (+0.10%)
Official Closing Price Updated: 7:38 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Sanofi-Aventis S.A.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Reasons to Buy Novavax Stock, and 1 Reason to Sell
Last year's stock market star is getting ready for its big moment -- or, has it already happened? 
Tags NVAX JNJ SNY
From Motley Fool
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
Investors should take notice of this four-way competition. 
Tags INCY SNY LLY
From Motley Fool
Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race
This small biotech could be like the tortoise in Aesop's famous fable. 
Tags SNY MRNA NVAX
From Motley Fool
‘Manufacturers and middlemen have created a vicious cycle of price increases’: Mark Cuban pledges to sell this $225 medication for $20
Americans pay $1,397 a year on average for prescription drugs and medical costs compared to $884 for Canadians. 
Tags LLY SNY NVO
From MarketWatch
Is Novavax's Growth Story Over?
The next few weeks could be critical for the biotech's coronavirus vaccine prospects. 
Tags Market News GILD SNY
From Motley Fool
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday
The FDA delivered a powerful shot of good news to the company. 
Tags SNY LXRX Market News
From Motley Fool
Is Regeneron Stock Heading to $590?
Rapid expansion beyond the Eylea franchise is causing analysts to raise their ratings on the big biotech. 
Tags Market News SNY REGN
From Motley Fool
Sanofi Spins Off an Industry-Leading Business
After divesting its active pharmaceutical ingredient segment, the slimmed-down company will have more time to focus on developing new blockbuster drugs. 
Tags Market News SNY REGN
From Motley Fool
3 Coronavirus Stocks to Stay Miles Away From in 2021
Their coronavirus projects fell behind, faltered, or failed. 
Tags SNY MRK CSL
From Motley Fool
Up 1,530% in 2020, Is Vaxart Still a Buy?
The biotech stock could still have big gains ahead, and not just because of its COVID-19 vaccine candidate. 
Tags VXRT Market News SNY
From Motley Fool
What's Next
Today I got a promotional mail reading” “What's next?” -- particularly appropriate today after yesterday's events disarray including the still buoyant stock market. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing
Moderna Inc (NASDAQ: MRNA), which received the fourth regulatory nod for its investigational coronavirus vaccine with the conditional ... 
Tags AMGN PFE RHHBY
From Benzinga
A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in ... 
Tags AYTU NEOS josh Disbrow
From Benzinga
3 Recession-Proof Healthcare Stocks to Buy for 2021
These stocks can handle whatever the new year has in store. 
Tags Market News DXCM ABT
From Motley Fool
Market Briefing For Tuesday, Jan. 5
A stiff hangover greeted the big-cap market to start the year, while relative stability or rebounds were seen in a number of small-cap stocks that struggled late in 2020. Reinforcing my suspicion about... 
Tags Pharma/Biotech Capital & Industrial Goods Technology
From Blogs - TalkMarkets
The Worst Mistake Novavax Investors Can Make Right Now
Investors will soon have data to judge management's big projections. 
Tags Market News PFE NVAX
From Motley Fool
3 Top Biotech Buyout Candidates in 2021
Big drugmakers could be attracted to these smaller players with promising pipelines. 
Tags BNTX ABBV BLUE
From Motley Fool
5 Big ETF Stories Of 2020 Worth Watching In 2021
After slipping into a bear market in late March, Wall Street made an astounding rebound with major indices soaring to historic highs. This is especially true against the backdrop of super-easy monetary... 
Tags Stocks / Equities ETFs
From Blogs - TalkMarkets
Week In Review: How Trump's Policies Moved Stocks -Saturday, Dec. 26
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly... 
Tags Stocks / Equities Capital & Industrial Goods Pharma/Biotech
From Blogs - TalkMarkets
Here's What Investors Need to Know About Sanofi and GlaxoSmithKline's COVID Vaccine Setback
Hopefully, the backup plan works. 
Tags SNY GSK Market News
From Motley Fool
Better Coronavirus Stock: Pfizer vs. BioNTech
One healthcare company is confident about its future while the other tries to recapture its former glory. 
Tags BNTX Market News RHHBY
From Motley Fool
Where Will Novavax Be in 1 Year?
Investors cheered for Novavax's science this year. Next year, they'll cheer for its revenue. 
Tags NVAX PFE SNY
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
The FDA's inability to inspect an overseas manufacturing facility is holding up an application for inclisiran. 
Tags ALNY AMGN SNY
From Motley Fool
2 Reasons It's Not Too Late to Buy BioNTech
The German biotech, which just went public last year, is a member of a coronavirus vaccine dream team. 
Tags REGN PFE SNY
From Motley Fool
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
The challenges for two big drugmakers could translate to opportunities for their rivals in the COVID-19 vaccine race. 
Tags BNTX GSK Market News
From Motley Fool
Dr. Fauci says Biden and Harris should receive COVID-19 vaccination ‘as soon as we possibly can’
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said, ‘You still want to protect people who are very important to our country right now.’ 
Tags BNTX DJIA AZN
From MarketWatch
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
A winning culture and proven science should make this stock a winner. 
Tags Market News REGN BAYR/Y
From Motley Fool
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
Hindsight is always 20/20. But in a year like 2020, it's probably better to err on the side of caution. 
Tags NVAX JNJ SNY
From Motley Fool
‘Flight to safety’: COVID-19 has made Americans rethink the kinds of places they want to work
‘The COVID-19 pandemic shifted the focus of job-seekers,’ a new study says. 
Tags Internet Hardware Textiles and Apparel Economy
From MarketWatch
European stocks and U.S. equity futures rise on COVID-19 vaccine optimism and hopes for a Washington stimulus deal
Stocks in Europe are kicking off the week with gains, as investors look on the brighter side, with optimism over vaccine rollouts and a stimulus deal out of Washington. The extension of Brexit talks... 
Tags PFE RDS/A FR:VIV
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.